An unusual case of ectopic ACTH syndrome

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 2, 2012, Pages 63-67

  Willhauck, M J ^a   Popperl G ^a   Rachinger, W ^a   Giese, A ^a   Auernhammer, C J ^a   Spitzweg, C ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

cabergoline; DOTA TATE PET; glucocorticoids; pituitary adenoma

Indexed keywords

CABERGOLINE; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; OCTREOTIDE; SOMATOSTATIN RECEPTOR 2; TETRAXETAN;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; CUSHING SYNDROME; DIAGNOSTIC IMAGING; DRUG EFFICACY; ECTOPIC CORTICOTROPIN PRODUCTION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR AFFINITY; SPHENOID SINUS; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ACTH SYNDROME, ECTOPIC; ADRENOCORTICOTROPIC HORMONE; CUSHING SYNDROME; FEMALE; HUMANS; MIDDLE AGED; NEUROENDOCRINE TUMORS; PARANASAL SINUS NEOPLASMS; SPHENOID SINUS; WHOLE BODY IMAGING;

EID: 84857057951     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0031-1297967     Document Type: Article

References (20)

1. Bethge H, Arlt W, Zimmermann U et al. Cushings syndrome due to an ectopic ACTH-secreting pituitary tumour mimicking occult paraneoplastic ectopic ACTH production. Clin Endocrinol (Oxf): 1999; 51 809 814 (Pubitemid 30052014)
2. Biller B M, Grossman A B, Stewart P M et al. Treatment of adrenocorticotropin-dependent Cushings syndrome: a consensus statement. J Clin Endocrinol Metab: 2008; 93 2454 2462 (Pubitemid 352008503)
3. de Bruin C, Pereira A M, Feelders R A et al. Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas. J Clin Endocrinol Metab: 2009; 94 1118 1124
4. Findling J W, Raff H. Cushings Syndrome: important issues in diagnosis and management. J Clin Endocrinol Metab: 2006; 91 3746 3753 (Pubitemid 44536836)
5. Gabriel M, Decristoforo C, Kendler D et al. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med: 2007; 48 508 518 (Pubitemid 47571404)
6. Hamon M, Coffin C, Courtheoux P et al. Case report: cushing disease caused by an ectopic intracavernous pituitary microadenoma: case report and review of the literature. J Comput Assist Tomogr: 2003; 27 424 426 (Pubitemid 36793195)
7. Haug A, Auernhammer C J, Wangler B et al. Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours. Eur J Nucl Med Mol Imaging: 2009; 36 765 770
8. Hori A. Suprasellar peri-infundibular ectopic adenohypophysis in fetal and adult brains. J Neurosurg: 1985; 63 113 115 (Pubitemid 15067281)
9. Kayani I, Bomanji J B, Groves A et al. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer: 2008; 112 2447 2455
10. McGrath P. Volume and histology of the human pharyngeal hypophysis. Aust NZ J Surg: 1967; 37 16 27
11. Miyoshi T, Otsuka F, Takeda M et al. Effect of cabergoline treatment on Cushings disease caused by aberrant adrenocorticotropin-secreting macroadenoma. J Endocrinol Invest: 2004; 27 1055 1059
12. Nieman L K, Biller B M, Findling J W et al. The diagnosis of Cushings syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab: 2008; 93 1526 1540 (Pubitemid 351656485)
13. Orth D N. Cushings syndrome. N Engl J Med: 1995; 332 791 803
14. Petrossians P, Ronci N, Valdes Socin H et al. ACTH silent adenoma shrinking under cabergoline. Eur J Endocrinol: 2001; 144 51 57 (Pubitemid 32126912)
15. Pivonello R, De Martino M C, Cappabianca P et al. The medical treatment of Cushings disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. J Clin Endocrinol Metab: 2009; 94 223 230
16. Pivonello R, Ferone D, de Herder W W et al. Dopamine receptor expression and function in corticotroph ectopic tumors. J Clin Endocrinol Metab: 2007; 92 65 69 (Pubitemid 46067510)
17. Pivonello R, Ferone D, Lamberts S W et al. Cabergoline plus lanreotide for ectopic Cushings syndrome. N Engl J Med: 2005; 352 2457 2458 (Pubitemid 40958451)
18. Rocheville M, Lange D C, Kumar U et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science: 2000; 288 154 157 (Pubitemid 30203051)
19. Suzuki J, Otsuka F, Ogura T et al. An aberrant ACTH-producing ectopic pituitary adenoma in the sphenoid sinus. Endocr J: 2004; 51 97 103 (Pubitemid 38405151)
20. Wajchenberg B L, Mendonca B B, Liberman B et al. Ectopic adrenocorticotropic hormone syndrome. Endocr Rev: 1994; 15 752 787